Form 4: Ventas Director Marguerite Nader Acquires Additional Shares Through Equity Program

Ventas, Inc. Director Marguerite M. Nader acquired 78.961 shares of common stock at $65.37 per share through the company's Non-Employee Directors' Equity Award Deferral Program.

Summary

• Marguerite M. Nader, a Director of Ventas, Inc. (VTR), acquired 78.961 shares of common stock.
• The acquisition occurred on July 17, 2025, at a price of $65.37 per share.
• The shares were acquired in the form of units under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program, adopted pursuant to the 2022 Incentive Plan.
• This acquisition resulted from dividend equivalents credited with respect to a dividend on Ventas' common stock paid on July 17, 2025.
• The units are payable solely in common stock and are subject to the terms of the deferral election and the Program.
• Following this transaction, Marguerite M. Nader beneficially owns a total of 21,215.393 shares of Ventas common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even through a routine equity program, indicates continued alignment of interests and confidence in the company, which is a positive signal.

Positives

• A Director's acquisition of additional shares, even through a deferral program, indicates continued alignment with shareholder interests and confidence in the company's future prospects.
• The acquisition is part of a structured equity award deferral program, reflecting a long-term commitment from the director.

Future Outlook

The document does not provide a future outlook or guidance; it details a past/scheduled insider transaction.

Industry Context

This Form 4 filing is specific to an insider transaction at Ventas, Inc., a healthcare real estate investment trust (REIT). It does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: The acquisition by a director may be perceived as a positive signal, reinforcing confidence in the company's leadership and future value.

Key Dates

Keywords

Ventas Inc, VTR, SEC Form 4, Insider Transaction, Director Share Acquisition, Equity Award Deferral Program, Common Stock, Dividend Reinvestment